|
Molecular residual disease (MRD) in solid tumors. |
| |
|
Employment - Flatiron Health |
Stock and Other Ownership Interests - Roche |
Research Funding - Flatiron Health |
| |
|
No Relationships to Disclose |
| |
|
Employment - Exact Sciences |
Stock and Other Ownership Interests - Exact Sciences |
Research Funding - Exact Sciences |
Travel, Accommodations, Expenses - Flatiron Health |
| |
|
Employment - Flatiron Health |
Stock and Other Ownership Interests - Roche |
Research Funding - Flatiron Health |
| |
|
Employment - Flatiron Health |
Stock and Other Ownership Interests - Roche |
Research Funding - Flatiron Health |
| |
|
Employment - Exact Sciences |
Stock and Other Ownership Interests - Exact Sciences |
Travel, Accommodations, Expenses - Exact Sciences |
| |
|
Employment - Exact Sciences |
Stock and Other Ownership Interests - Exact Sciences |
Research Funding - Exact Sciences (Inst) |
Travel, Accommodations, Expenses - Exact Sciences |
| |
|
Employment - Flatiron Health |
Stock and Other Ownership Interests - Roche |
| |
Amanda Rodriguez-Sullivan |
Employment - Flatiron Health |
Stock and Other Ownership Interests - Roche |
Research Funding - Flatiron Health |
| |
|
Employment - Exact Sciences |
Leadership - Cancer Prevention Movement |
Stock and Other Ownership Interests - Exact Sciences; LabCorp |
Travel, Accommodations, Expenses - Exact Sciences |
| |
|
Employment - Flatiron Health |
Stock and Other Ownership Interests - Roche |
Research Funding - Flatiron Health |
| |
|
Employment - Exact Sciences |
| |
|
Employment - Exact Sciences |
Stock and Other Ownership Interests - Exact Sciences |
| |
|
Employment - Flatiron Health |
Stock and Other Ownership Interests - Roche |
Research Funding - Flatiron Health |
| |
|
Employment - Flatiron Health, Inc, which is an independent member of the Roche group |
Stock and Other Ownership Interests - Flatiron Health; Roche Pharma AG |
Patents, Royalties, Other Intellectual Property - US Patent (20020031515): Methods of therapy for cancers characterized by over expression of the HER2 receptor protein |